CSF1 and acute myeloid leukemia: The colony-stimulating factor-1 (CSF-1, also called M-CSF), which controls the survival, proliferation, differentiation, and polarization of MΦs by binding to its receptor, the CSF1R, is a promising therapeutic target in aggressive tumors and possibly in AML [24].